High-performance liquid chromatographic determination of creatine kinase activity influenced by methylglyoxal

Biomedical Chromatography

Volumn 23, Issue 2, 2009, Pages 170-174

  Peng, Xiaofang ^a   Ma, Jinyu ^a,b   Cheng, Ka Wing ^a   Chen, Bo ^b   Chen, Feng ^a   Wang, Mingfu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Creatine kinase activity; Glycation; Ion pair HPLC; Methyglyoxal

Indexed keywords

ENZYMES; GLYCOSYLATION;

ADVANCED GLYCATION END PRODUCTS; CHROMATOGRAPHIC DETERMINATION; CREATINE KINASE; CREATINE KINASE ACTIVITY; GLYCATION; ION-PAIR HPLC; KINASE ACTIVITY; METHYGLYOXAL; METHYLGLYOXAL; PERFORMANCE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINOGUANIDINE; CREATINE KINASE; METHYLGLYOXAL;

ACCURACY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; ION PAIR CHROMATOGRAPHY; NONHUMAN; PROTEIN DEPLETION; RABBIT; SCREENING TEST;

EID: 65349196269     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1099     Document Type: Article

References (22)

1. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR and Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochemical Journal 1997; 324: 565-570.
2. Brock JW, Cotham WE, Thorpe SR, Baynes JW and Ames JM. Detection and identification of arginine modifications on methylglyoxal-modified ribonuclease by mass spectrometric analysis. Journal of Mass Spectrometry 2007; 42: 89-100.
3. Brownlee M. Glycation and diabetic complications. Diabetes 1994; 43: 836-841.
4. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine 1995; 46: 223-234.
5. Corstjens H, Declercq L, Hellemans L, Sente I and Maes D. Prevention of oxidative damage that contributes to the loss of bioenergetic capacity in ageing skin. Experimetal Gerontology 2007; 42: 924-929.
6. Cotham WE, Metz TO, Ferguson PL, Brock JW, Hinton DJ, Thorpe SR, Baynes JW and Ames JM. Proteomic analysis of arginine adducts on glyoxal-modified ribonuclease. Molecular and Cellular Proteomics 2004; 3: 1145-1153.
7. Faure P, Troncy L, Lecomte M, Wiernsperger N, Lagarde M, Ruggiero D and Halimi S. Albumin antioxidant capacity is modified by methylglyoxal. Diabetes and Metabolism 2005; 31: 169-177.
8. Kawamoto Y, Shinozuka K, Kunitomo M and Haginaka J. Determination of ATP and its metabolites released from rat caudal artery by isocratic ion-pair reversed-phase high-performance liquid chromatography. Analytical Biochemistry 1998; 262: 33-38.
9. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y and Takahashi K. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. American Journal of Pathology 1995; 147: 654-667.
10. Meade SJ, Miller AG and Gerrard JA. The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-activity study. Bioorganic and Medicinal Chemistry 2003; 11: 853-862.
11. Mekhfi H, Veksler V, Mateo P, Maupoil V, Rochette L and Ventura-Clapier R. Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils. Circulation Research 1996; 78: 1016-1027.
12. Meyer LE, Machado LB, Santiago AP, da-Silva WS, De Felice FG, Holub O, Oliveira MF and Galina A. Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. Journal of Biological Chemistry 2006; 281: 37361-37371.
13. Ou WB, Wang RS and Zhou HM. Conformational changes and inactivation of rabbit muscle creatine kinase in dimethyl sulfoxide solutions. Biochemistry and Cell Biology 2002; 80: 427-434.
14. Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T and Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. Journal of Biological Chemistry 1999; 274: 18492-18502.
15. Sudo J, Terui J, Iwase H and Kakuno K. Assay of ATPase and Na,K-ATPase activity using high-performance liquid chromatographic determination of ADP derived from ATP. Journal of Chromatogr B Biomedical Sciences and Applications 2000; 744: 19-23.
16. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Archives of Biochemistry and Biophysics 2003; 419: 31-40.
17. Thornalley PJ. Dicarbonyl intermediates in the maillard reaction. Annals of the New York Academy Sciences 2005; 1043: 111-117.
18. Thornalley PJ, Langborg A and Minhas HS. Formation of glyoxal, methyl-glyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochemical Journal 1999; 344: 109-116.
19. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K and Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 4766-4770.
20. Webster J, Urban C, Berbaum K, Loske C, Alpar A, Gartner U, de Arriba SG, Arendt T and Munch G. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotoxicity Research 2005; 7: 95-101.
21. Zeng J and Davies MJ. Protein and low molecular mass thiols as targets and inhibitors of glycation reactions. Chemical Research in Toxicology 2006; 19: 1668-1676.
22. Zeng J, Dunlop RA, Rodgers KJ and Davies MJ. Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochemical Journal 2006; 398: 197-206.